Shopping Cart

Crescor Eze 10mg/10mg Tablets (10s)

Manufacturer:

Martin Dow

Ingredients:

Ezetimibe, Rosuvastatin,

Form:

Size:

Rs. 410.00
In stock
SKU
385479

Description

Crescor Eze is a prescription fixed-dose combination tablet containing rosuvastatin and ezetimibe. It helps lower elevated LDL cholesterol and other blood lipids when diet and lifestyle measures alone are insufficient.

  • Manufacturer Name: Martin Dow
  • Drug Class: Lipid-lowering agent; HMG-CoA reductase inhibitor plus cholesterol absorption inhibitor
  • Dosage Form: Tablet
  • Storage: Store at room temperature, generally below 25°C, in a dry place protected from heat, light, and moisture. Keep out of reach of children.
  • Pack Size: Pack of 10 Tablets

Crescor Eze 10mg/10mg Tablets (10s) Available Online in Pakistan

Dwatson offers Crescor Eze 10mg/10mg Tablets (10s) at Rs. 410, with fast, discreet delivery across Pakistan.

Ingredients

  • Rosuvastatin 10 mg
  • Ezetimibe 10 mg

Benefits

  • Reduction of elevated LDL cholesterol and total cholesterol
  • Management of primary hypercholesterolemia and mixed dyslipidemia
  • Additional lipid lowering when rosuvastatin alone does not provide adequate control
  • Reduction of cardiovascular risk as part of an overall treatment plan including diet and lifestyle measures

Usage & Safety

For Adult

  • Take one tablet once daily, or as directed by the prescribing physician.
  • It may be taken with or without food, preferably at the same time each day.
  • Swallow the tablet whole with water; do not crush or chew unless specifically instructed.
  • Dosage may require adjustment according to LDL cholesterol response, kidney function, liver function, and interacting medicines.

For Children

  • Safety and effectiveness of this fixed-dose combination in children and adolescents have not been established.
  • Not routinely recommended for individuals under 18 years unless prescribed and monitored by a specialist.
  • Pediatric lipid disorders require specialist assessment, dietary management, and age-appropriate therapy.

Side Effects

  • Common: headache, nausea, abdominal discomfort, diarrhea, constipation, or muscle aches.
  • Laboratory changes may include increased liver enzymes or creatine kinase.
  • Seek urgent medical attention for severe or unexplained muscle pain, weakness, dark urine, jaundice, severe allergic reactions, or facial and throat swelling.
  • Rare serious effects include myopathy, rhabdomyolysis, liver injury, and severe hypersensitivity reactions.

Contraindications

  • Do not use in patients with hypersensitivity to rosuvastatin, ezetimibe, or any tablet ingredient.
  • Contraindicated during pregnancy; discontinue and contact a healthcare professional if pregnancy occurs.
  • Do not use while breastfeeding unless specifically advised by a specialist.
  • Contraindicated in active liver disease or unexplained persistent elevations of liver enzymes.
  • Use cautiously in severe kidney impairment, history of muscle disease, untreated hypothyroidism, or heavy alcohol use.

Precautions & Warnings

  • Cyclosporine, gemfibrozil, some antiviral medicines, and other medicines that increase rosuvastatin exposure may substantially increase muscle toxicity risk.
  • Other fibrates, high-dose niacin, colchicine, or other medicines associated with muscle injury may increase the risk of myopathy.
  • Warfarin and related anticoagulants may require closer monitoring of coagulation parameters.
  • Bile-acid sequestrants can reduce ezetimibe absorption; take this medicine at least 2 hours before or 4 hours after such products.
  • Aluminium- or magnesium-containing antacids may reduce rosuvastatin absorption; separate dosing as advised by a healthcare professional.
  • Tell the prescriber about all prescription medicines, supplements, and herbal products before starting treatment. Limit excessive alcohol intake.

Pregnancy

  • Do not use during pregnancy because cholesterol-lowering treatment is generally not needed during pregnancy and may pose fetal risk.
  • Women who could become pregnant should discuss appropriate contraception with their healthcare professional.
  • Breastfeeding is not recommended during treatment unless a specialist determines that treatment is necessary and provides specific guidance.

Description

Crescor Eze is a prescription fixed-dose combination tablet containing rosuvastatin and ezetimibe. It helps lower elevated LDL cholesterol and other blood lipids when diet and lifestyle measures alone are insufficient.

  • Manufacturer Name: Martin Dow
  • Drug Class: Lipid-lowering agent; HMG-CoA reductase inhibitor plus cholesterol absorption inhibitor
  • Dosage Form: Tablet
  • Storage: Store at room temperature, generally below 25°C, in a dry place protected from heat, light, and moisture. Keep out of reach of children.
  • Pack Size: Pack of 10 Tablets

Crescor Eze 10mg/10mg Tablets (10s) Available Online in Pakistan

Dwatson offers Crescor Eze 10mg/10mg Tablets (10s) at Rs. 410, with fast, discreet delivery across Pakistan.

Ingredients

  • Rosuvastatin 10 mg
  • Ezetimibe 10 mg

Benefits

  • Reduction of elevated LDL cholesterol and total cholesterol
  • Management of primary hypercholesterolemia and mixed dyslipidemia
  • Additional lipid lowering when rosuvastatin alone does not provide adequate control
  • Reduction of cardiovascular risk as part of an overall treatment plan including diet and lifestyle measures

Usage & Safety

For Adult

  • Take one tablet once daily, or as directed by the prescribing physician.
  • It may be taken with or without food, preferably at the same time each day.
  • Swallow the tablet whole with water; do not crush or chew unless specifically instructed.
  • Dosage may require adjustment according to LDL cholesterol response, kidney function, liver function, and interacting medicines.

For Children

  • Safety and effectiveness of this fixed-dose combination in children and adolescents have not been established.
  • Not routinely recommended for individuals under 18 years unless prescribed and monitored by a specialist.
  • Pediatric lipid disorders require specialist assessment, dietary management, and age-appropriate therapy.

Side Effects

  • Common: headache, nausea, abdominal discomfort, diarrhea, constipation, or muscle aches.
  • Laboratory changes may include increased liver enzymes or creatine kinase.
  • Seek urgent medical attention for severe or unexplained muscle pain, weakness, dark urine, jaundice, severe allergic reactions, or facial and throat swelling.
  • Rare serious effects include myopathy, rhabdomyolysis, liver injury, and severe hypersensitivity reactions.

Contraindications

  • Do not use in patients with hypersensitivity to rosuvastatin, ezetimibe, or any tablet ingredient.
  • Contraindicated during pregnancy; discontinue and contact a healthcare professional if pregnancy occurs.
  • Do not use while breastfeeding unless specifically advised by a specialist.
  • Contraindicated in active liver disease or unexplained persistent elevations of liver enzymes.
  • Use cautiously in severe kidney impairment, history of muscle disease, untreated hypothyroidism, or heavy alcohol use.

Precautions & Warnings

  • Cyclosporine, gemfibrozil, some antiviral medicines, and other medicines that increase rosuvastatin exposure may substantially increase muscle toxicity risk.
  • Other fibrates, high-dose niacin, colchicine, or other medicines associated with muscle injury may increase the risk of myopathy.
  • Warfarin and related anticoagulants may require closer monitoring of coagulation parameters.
  • Bile-acid sequestrants can reduce ezetimibe absorption; take this medicine at least 2 hours before or 4 hours after such products.
  • Aluminium- or magnesium-containing antacids may reduce rosuvastatin absorption; separate dosing as advised by a healthcare professional.
  • Tell the prescriber about all prescription medicines, supplements, and herbal products before starting treatment. Limit excessive alcohol intake.

Pregnancy

  • Do not use during pregnancy because cholesterol-lowering treatment is generally not needed during pregnancy and may pose fetal risk.
  • Women who could become pregnant should discuss appropriate contraception with their healthcare professional.
  • Breastfeeding is not recommended during treatment unless a specialist determines that treatment is necessary and provides specific guidance.
More Information
Manufacturer Martin Dow
Ingredients Ezetimibe, Rosuvastatin
Size Pack of 10 Tablets
Prescription Required No
Form Tablets
PrePayment No
FreeShipment No
Top Selling No
Hot Deals No
Sponsored No
Medicated No
Copyright © 2025 D. Watson Chemist & Super Store. All rights reserved.